Showing results (231-240 of 257) with videos related to
Sort By:
Pageof 26
Cancer|April 23, 2008
Recruiting and retaining breast cancer survivors into a randomized controlled exercise trial: the Yale Exercise and Survivorship StudyMelinda L Irwin, Lisa Cadmus, Marty Alvarez-Reeves, et al.Journal of Clinical Medicine|September 10, 2021
Psychiatric History and Overactive Bladder Symptom Severity in Ambulatory Urogynecological PatientsArtur Rogowski, Maria Krowicka-Wasyl, Ewa Chotkowska, et al.The ISME Journal|September 14, 2023
Microbial metabolomic responses to changes in temperature and salinity along the western Antarctic PeninsulaH M Dawson, E Connors, N G Erazo, et al.Journal of Medicinal Chemistry|August 2, 2017
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive ActivityAdam Bucki, Monika Marcinkowska, Joanna Śniecikowska, et al.European Journal of Medicinal Chemistry|February 28, 2020
Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD)Adam Bucki, Monika Marcinkowska, Joanna Śniecikowska, et al.Cancer Research|April 17, 2004
A novel founder CHEK2 mutation is associated with increased prostate cancer riskCezary Cybulski, Tomasz Huzarski, Bohdan Górski, et al.Fundamental & Clinical Pharmacology|June 15, 2024
Pharmacological treatment for mental health illnesses in adults receiving dialysis: A scoping reviewJenny Wichart, Peter Yoeun, Tracy Chin, et al.Stem Cell Research & Therapy|August 15, 2023
SDF-1 and NOTCH signaling in myogenic cell differentiation: the role of miRNA10a, 425, and 5100Bartosz Mierzejewski, Iwona Grabowska, Zuzanna Michalska, et al.Stem Cell Research & Therapy|August 10, 2021
Hypoxia preconditioned bone marrow-derived mesenchymal stromal/stem cells enhance myoblast fusion and skeletal muscle regenerationKarolina Archacka, Iwona Grabowska, Bartosz Mierzejewski, et al.European Journal of Medicinal Chemistry|August 26, 2016
Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT<sub>6</sub> receptor antagonists. Design, synthesis and biological evaluationAnna Więckowska, Marcin Kołaczkowski, Adam Bucki, et al.Pageof 26